Search Within

Andreas Felix Hottinger

Formats
  1. Journal Article (8)
  2. Meeting Abstract (5)
  3. Book Section (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (10)
  2. Surgery (6)
  3. Biostatistics Service (5)
  4. Epidemiology and Biostatistics (5)
  5. Neuroradiology Service (5)
  6. Population Sciences Research Program (5)

More Groups

People
  1. Lisa De Angelis (10)
  2. Lauren Abrey (9)
  3. Adilia Hormigo (8)
  4. Eric Holland (6)
  5. Martin Fleisher (6)
  6. Katherine Panageas (5)

More People

Years
  1. 2013 (1)
  2. 2011 (3)
  3. 2009 (2)
  4. 2008 (2)
  5. 2007 (3)
  6. 2006 (3)
Publications
  1. Journal of Clinical Oncology (3)
  2. Neuro-Oncology (3)
  3. Journal of Neuro-Oncology (2)
  4. Annals of Neurology (1)
  5. Current Cancer Therapy Reviews (1)
  6. Current Neurology and Neuroscience Reports (1)

More Publications

Publishers
  1. Springer (4)
  2. American Society of Clinical Oncology (3)
  3. Oxford University Press (3)
  4. Bentham Science Publishers (1)
  5. Current Medicine Group (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
    Journal Article

    Omuro, A.; Chan, T. A.; Abrey, L. E.; Khasraw, M.; Reiner, A. S.; Kaley, T. J.; De Angelis, L. M.; Lassman, A. B.; Nolan, C. P.; Gavrilovic, I. T.; more...
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Serum biomarkers
    Book Section

    Hottinger, A. F.; Hormigo, A.
    In Schwab, M. (Eds.) Encyclopedia of Cancer. 3rd ed (2011)

    Fulltext@MSK | Save
  • Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas
    Journal Article

    Iwamoto, F. M.; Hottinger, A. F.; Karimi, S.; Riedel, E.; Dantis, J.; Jahdi, M.; Panageas, K. S.; Lassman, A. B.; Abrey, L. E.; Fleisher, M.; more...
    Journal of Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma
    Journal Article

    Hottinger, A. F.; Iwamoto, F. M.; Karimi, S.; Riedel, E.; Dantis, J.; Park, J.; Panageas, K. S.; Lassman, A. B.; Abrey, L. E.; Fleisher, M.; more...
    Annals of Neurology (2011)

    Fulltext@MSK | Save
  • Neurological outcome of long-term glioblastoma survivors
    Journal Article

    Hottinger, A. F.; Yoon, H.; Deangelis, L. M.; Abrey, L. E.
    Journal of Neuro-Oncology (2009)

    Fulltext@MSK | Save
  • Neuro-oncology of neurofibromatosis type 1
    Journal Article

    Hottinger, A. F.; Khakoo, Y.
    Current Treatment Options in Neurology (2009)

    Fulltext@MSK | Save
  • A longitudinal prospective study of YKL-40 and matrix metalloproteinase-9 (MMP-9) as serum tumor markers in gliomas
    Meeting Abstract

    Iwamoto, F. M.; Hottinger, A. F.; Karimi, S.; Riedel, E.; Panageas, K.; Gu, B.; Rao, J.; Fleisher, M.; Holland, E.; DeAngelis, L. M.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Ykl-40 and matrix metalloproteinase-9 (Mmp-9) as serum tumor markers in gliomas
    Meeting Abstract

    Iwamoto, F.; Hottinger, A.; Jahdi, M.; Dantis, J.; Karimi, S.; Riedel, E.; Panageas, K.; Gu, B.; Rao, J.; Fleisher, M.; more...
    Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • Clinical outcome of glioblastoma multiforme patients with long-term survival
    Meeting Abstract

    Yoon, H.; Hottinger, A. F.; DeAngelis, L. M.; Lassman, A. B.; Abrey, L. E.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Update on the management of familial central nervous system tumor syndromes
    Journal Article

    Hottinger, A. F.; Khakoo, Y.
    Current Neurology and Neuroscience Reports (2007)

    Fulltext@MSK | Save